House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Infectious diseases

Sinusitis (acute): antimicrobial prescribing

NICE · 2017 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE NG79 organizes acute sinusitis care by duration, trajectory and risk of complications. Most uncomplicated episodes can be managed with symptom relief and safety-net advice. Persistent symptoms do not automatically establish a bacterial infection; urgent assessment takes priority when systemic, orbital or intracranial complications are suspected.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Assess duration, deterioration and complications

  • A bacterial cause becomes more likely when several features coexist: symptoms beyond 10 days, purulent or discoloured discharge, severe localized unilateral pain, fever, or deterioration after initial improvement. Viral and bacterial disease remain difficult to distinguish. [1]
  • For symptoms lasting around 10 days or less, do not offer antibiotics. Explain that the usual illness lasts 2–3 weeks, discuss self-care and advise review for rapid deterioration, failure to improve after 3 weeks or becoming systemically very unwell. [1]
  • Reassess rapid or substantial deterioration for an alternative diagnosis such as dental infection and for serious illness. If deterioration occurs despite treatment, include previous antibiotic exposure and possible resistant organisms in the reassessment. [1]
  • At any duration, offer immediate antibiotics for people who are systemically very unwell, have signs of more serious illness or are at high risk of complications. [1]
  • Refer to hospital for severe systemic infection, periorbital swelling or cellulitis, displaced globe, diplopia, ophthalmoplegia or newly reduced vision. Frontal-bone swelling, meningitic signs, severe frontal headache and focal neurological signs also warrant hospital referral. [1]

Use a selective approach after persistent symptoms

  • For symptoms lasting around 10 days or more without improvement, consider either no antibiotic or a back-up prescription. Antibiotics offer little change in symptom duration or recovery proportion, while nausea and diarrhoea are possible harms. [1]
  • If providing a back-up antibiotic, explain that it is not needed immediately. Start it if there is no improvement within 7 days or rapid or significant worsening at any point. Seek review for deterioration despite antibiotics or after stopping because of intolerance. [1]
  • In adults and children aged at least 12 with symptoms lasting around 10 days or more without improvement, consider a high-dose nasal corticosteroid for 14 days. It may improve symptoms without shortening the illness. Consider correct spray technique and systemic steroid exposure, especially when another corticosteroid is already used. [1]
  • Studied nasal regimens were mometasone 200 micrograms twice daily or fluticasone 110 micrograms twice daily. NICE identifies this high-dose sinusitis use as off-label. [1]

Prescribe for the applicable population

  • For adults aged at least 18 when an oral antibiotic is indicated, NICE lists phenoxymethylpenicillin 500 mg four times daily for 5 days. For severe illness or high complication risk, the listed first choice is co-amoxiclav 500/125 mg three times daily for 5 days. [1]
  • For non-pregnant adults with penicillin allergy or intolerance, options are doxycycline 200 mg on the first day followed by 100 mg daily for 4 days, or clarithromycin 500 mg twice daily for 5 days. Where a macrolide is needed in pregnancy, NICE prefers erythromycin after weighing benefit and harm. [1]
  • If worsening after at least 2–3 days of first-choice treatment, the adult second-choice regimen is co-amoxiclav 500/125 mg three times daily for 5 days. Consult local microbiology if co-amoxiclav was already used, penicillin allergy limits second choice, or second-choice treatment is failing. [1]
  • Children require the age- and weight-specific table and formulation checks; adult doses must not be extrapolated. Doxycycline is contraindicated below 12 years. Adjust prescribing for renal or hepatic impairment, pregnancy and breastfeeding as applicable. [1]

Explain the limits of symptom treatments

  • Consider paracetamol or ibuprofen for pain or fever, using the separate fever pathway for children under 5. Nasal saline or decongestants may be tried, but evidence for congestion relief is insufficient. [1]
  • NICE found no evidence supporting oral decongestants, antihistamines, mucolytics, steam inhalation or warm face packs for acute sinusitis. [1]

Limitations and use

  • This is a summary of the NICE UK antimicrobial pathway. Local resistance, formularies, allergy assessment and patient factors govern application in another setting.
  • Paediatric antibiotic quantities, pregnancy erythromycin schedules and renal or hepatic adjustments are not reproduced. Use the complete prescribing table and an appropriate formulary before prescribing.
  • An outpatient antibiotic pathway does not replace urgent hospital assessment for orbital, intracranial or severe systemic complications.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Sinusitis (acute): antimicrobial prescribing

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
NICE
First published
27 October 2017
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Assess duration, deterioration and complications
  • Use a selective approach after persistent symptoms
  • Prescribe for the applicable population
  • Explain the limits of symptom treatments
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House